{"address1": "Four Tower Bridge", "address2": "Suite 200 200 Barr Harbor Drive", "city": "West Conshohocken", "state": "PA", "zip": "19428", "country": "United States", "phone": "267 824 2827", "website": "https://www.madrigalpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. The company offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.", "fullTimeEmployees": 528, "companyOfficers": [{"maxAge": 1, "name": "Mr. William J. Sibold", "age": 58, "title": "CEO, President & Director", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 1666801, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Rebecca A. Taub M.D.", "age": 72, "title": "Founder, Chief Medical Officer, President of Research & Development and Director", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 928108, "exercisedValue": 0, "unexercisedValue": 64142484}, {"maxAge": 1, "name": "Ms. Carole  Huntsman", "age": 58, "title": "Chief Commercial Officer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 94001, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mardi C. Dier", "age": 60, "title": "CFO & Senior VP", "yearBorn": 1964, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Underwood", "title": "Senior Vice President of Business Planning & Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ronald  Filippo", "title": "Chief Information Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Tina E. Ventura", "title": "Chief Investor Relations Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Shannon  Kelley", "title": "General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Clint  Wallace", "title": "Chief Human Resources Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Edward  Chiang", "title": "Senior Vice President of Clinical & Technical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 5, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://ir.syntapharma.com/phoenix.zhtml?c=147988&p=irol-irhome", "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 331.23, "open": 331.76, "dayLow": 320.7, "dayHigh": 334.9265, "regularMarketPreviousClose": 331.23, "regularMarketOpen": 331.76, "regularMarketDayLow": 320.7, "regularMarketDayHigh": 334.9265, "payoutRatio": 0.0, "beta": -0.412, "forwardPE": -23.207737, "volume": 331086, "regularMarketVolume": 331086, "averageVolume": 404818, "averageVolume10days": 248430, "averageDailyVolume10Day": 248430, "bid": 322.45, "ask": 325.91, "bidSize": 1, "askSize": 1, "marketCap": 7153543680, "fiftyTwoWeekLow": 189.0, "fiftyTwoWeekHigh": 377.46, "priceToSalesTrailing12Months": 39.712566, "fiftyDayAverage": 333.4148, "twoHundredDayAverage": 287.35986, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 6346876928, "profitMargins": -2.58638, "floatShares": 11365807, "sharesOutstanding": 22080200, "sharesShort": 4094246, "sharesShortPriorMonth": 3795295, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.18540001, "heldPercentInsiders": 0.08745, "heldPercentInstitutions": 1.051, "shortRatio": 8.96, "shortPercentOfFloat": 0.2647, "impliedSharesOutstanding": 22080200, "bookValue": 34.283, "priceToBook": 9.450165, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -465892000, "trailingEps": -21.9, "forwardEps": -13.96, "lastSplitFactor": "1:35", "lastSplitDate": 1469404800, "enterpriseToRevenue": 35.234, "enterpriseToEbitda": -12.776, "52WeekChange": 0.32112706, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 323.98, "targetHighPrice": 539.0, "targetLowPrice": 239.0, "targetMeanPrice": 414.06668, "targetMedianPrice": 405.0, "recommendationMean": 1.5625, "recommendationKey": "buy", "numberOfAnalystOpinions": 15, "totalCash": 926251008, "totalCashPerShare": 41.949, "ebitda": -496779008, "totalDebt": 119570000, "quickRatio": 5.79, "currentRatio": 6.102, "totalRevenue": 180132992, "debtToEquity": 15.85, "revenuePerShare": 8.468, "returnOnAssets": -0.36983, "returnOnEquity": -0.80346, "grossProfits": 173900000, "freeCashflow": -296991264, "operatingCashflow": -455572000, "grossMargins": 0.9654, "ebitdaMargins": -2.75785, "operatingMargins": -0.64843005, "financialCurrency": "USD", "symbol": "MDGL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1170772200000, "preMarketChange": -1.1800232, "preMarketChangePercent": -0.36422715, "shortName": "Madrigal Pharmaceuticals, Inc.", "longName": "Madrigal Pharmaceuticals, Inc.", "corporateActions": [], "preMarketTime": 1743595594, "regularMarketTime": 1743537601, "exchange": "NMS", "messageBoardId": "finmb_144939852", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -2.1888113, "regularMarketPrice": 323.98, "cryptoTradeable": false, "marketState": "PRE", "preMarketPrice": 322.8, "regularMarketChange": -7.25, "regularMarketDayRange": "320.7 - 334.9265", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 404818, "fiftyTwoWeekLowChange": 134.98001, "fiftyTwoWeekLowChangePercent": 0.71417993, "fiftyTwoWeekRange": "189.0 - 377.46", "fiftyTwoWeekHighChange": -53.47998, "fiftyTwoWeekHighChangePercent": -0.14168383, "fiftyTwoWeekChangePercent": 32.112705, "dividendDate": 1469404800, "earningsTimestamp": 1736768700, "earningsTimestampStart": 1746448200, "earningsTimestampEnd": 1746793800, "earningsCallTimestampStart": 1740574800, "earningsCallTimestampEnd": 1740574800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -21.9, "epsForward": -13.96, "epsCurrentYear": -12.58135, "priceEpsCurrentYear": -25.750814, "fiftyDayAverageChange": -9.434784, "fiftyDayAverageChangePercent": -0.028297435, "twoHundredDayAverageChange": 36.620148, "twoHundredDayAverageChangePercent": 0.12743655, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.6 - Buy", "displayName": "Madrigal Pharmaceuticals", "trailingPegRatio": null}